-60% p.a.
bt_headshoulder_sharpeopt_mixed
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -60 Days active 408 …
source: Benzinga
tickers affected by this
| ticker | polarity | why? |
|---|---|---|
| SPGI | positively | The coverage initiation on S&P Global Inc. (SPGI) by Mizuho analyst Sean Kennedy with an Outperform rating and a price target of $599 suggests strong confidence in the company’s future performance. This rating upgrade will likely lead a number of investors who follow analyst recommendations to buy into it. Furthermore, the analyst’s recommendation acknowledges expected positive changes in SPGI’s outlook, which can foster a more positive sentiment among investors and drive up the stock price. |
| RNA | positively | The ticker RNA (Avidity Biosciences, Inc.) is expected to be positively affected by the Outperform rating and the price target of $72 set by BMW Capital analyst Kostas Biliouris. This rating suggests a strong potential for the stock to outperform the broader market, which can attract more investors and drive up the share price. The significant upside indicated by the price target compared to the current closing price of $29.58, could add investor confidence and enthusiasm for the stock. |
| RADX | positively | Radiopharm Theranostics Limited (RADX) is likely to experience a positive impact due to the new coverage initiated by B. Riley Securities. Investors may take notice of the Buy rating and $15 price target, potentially increasing buying interest and driving up the stock’s value. |
our strategies and bots using these tickers
summary
Top Wall Street Analysts Initiate Coverage on Key Stocks
Top Wall Street analysts have initiated coverage on several notable stocks, providing valuable insights and price targets for investors.
Avidity Biosciences, Inc. (RNA)
BMO Capital analyst Kostas Biliouris initiated coverage on Avidity Biosciences, Inc. (RNA) with an Outperform rating and a price target of $72. Avidity Biosciences shares closed at $29.58 on Tuesday.
Radiopharm Theranostics Limited (RADX)
B. Riley Securities analyst Yuan Zhi initiated coverage on Radiopharm Theranostics Limited (RADX) with a Buy rating and a price target of $15. Radiopharm Theranostics shares closed at $5.75 on Tuesday.
Talen Energy Corporation (TLN)
Morgan Stanley analyst David Arcaro initiated coverage on Talen Energy Corporation (TLN) with an Overweight rating and a price target of $243. Talen Energy shares closed at $176.56 on Tuesday.
S&P Global Inc. (SPGI)
Mizuho analyst Sean Kennedy initiated coverage on S&P Global Inc. (SPGI) with an Outperform rating and a price target of $599. S&P Global shares closed at $480.00 on Tuesday.
Upwork Inc. (UPWK)
Scotiabank analyst Nat Schindler initiated coverage on Upwork Inc. (UPWK) with a Sector Perform rating and a price target of $15. Upwork shares closed at $13.39 on Tuesday.
